Genetic Mutations
356 articles
![](https://letswinpc.org/wp-content/uploads/2022/09/LW_GeneticMutations_Green_crop_@1x-300x300.png)
Having a genetic mutation can make all the difference in treatment choices, and even longer-term survival. Learn more about the importance of genetic testing and molecular profiling.
Chemotherapy Regimen for Post-Surgery PNET Patients
Will a chemotherapy combination be effective against PNET after high-grade tumors are surgically removed? A clinical trial takes a closer look.
Chemotherapy Plus Immunotherapy Trial Shows Promise
Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.
Leveraging Nanoparticle Technology for Paclitaxel Delivery in Pancreatic Cancer Patients
Dr. Allyson Ocean explains why nanoparticle delivery technology for getting paclitaxel to the tumor could be advantageous for patients.
Felix 2.0 Builds Upon Artificial Intelligence Earlier Detection Successes
Can artificial intelligence help find pancreatic cancer sooner? Dr. Elliot Fishman thinks so, and has been working to make it happen.
2024 AACR Meeting Update
Some of the highlights of the latest pancreatic cancer research from the 2024 AACR meeting include the mRNA vaccine, and a liquid biopsy.
Helene Andrews-Polymenis, Ph.D., D.V.M.
A native of the Pacific Northwest, Dr. Helene Andrews-Polymenis earned an A.B. in Biology from Brown University (1989), Ph.D. in Molecular Biology/Microbiology from Tufts University (1999), and a D.V.M. from Texas A&M University (TAMU) in 2001. After completing her postdoctoral training, Dr. Andrews-Polymenis joined the faculty in the Department of Microbial and Molecular Pathogenesis at […]
Positive Results For Borderline Resectable Disease Pilot Study
Dr. Zev Wainberg provides details on a trial of chemotherapy and immunotherapy for patients with borderline resectable pancreatic cancer.